000 01071 a2200313 4500
005 20250513093829.0
264 0 _c19961113
008 199611s 0 0 eng d
022 _a0012-6667
024 7 _a10.2165/00003495-199600511-00008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRubinstein, E
245 0 0 _aFuture prospects and therapeutic potential of streptogramins.
_h[electronic resource]
260 _bDrugs
_c1996
300 _a38-42 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aBacteremia
_xmicrobiology
650 0 4 _aForecasting
650 0 4 _aGram-Positive Bacterial Infections
_xepidemiology
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMethicillin Resistance
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aVirginiamycin
_xtherapeutic use
700 1 _aKeller, N
773 0 _tDrugs
_gvol. 51 Suppl 1
_gp. 38-42
856 4 0 _uhttps://doi.org/10.2165/00003495-199600511-00008
_zAvailable from publisher's website
999 _c8721967
_d8721967